UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 17, 2013 1:30 P.M.
Form:
S-3
CIK:
0000850261
Company Name:
Sorrento Therapeutics, Inc.
File Number:
333-192025